Publikationen von Alexander Yassouridis

Then Bergh, F.; Kümpfel, T.; Schumann, E.; Held, U.; Schwan, M.; Blazevic, M.; Wismüller, A.; Holsboer, F.; Yassouridis, A.; Uhr, M. et al.; Weber, F.; Daumer, M.; Trenkwalder, C.; Auer, D. P.: Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurology 6 (19), doi:10.1186/1471-2377-6-19 (2006)

Kovacs, L.; Yassouridis, A.; Zimmermann, A.; Brockmann, G.; Wohnl, A.; Blaschke, M.; Eder, M.; Schwenzer-Zimmerer, K.; Rosenberg, R.; Papadopulos, N. A. et al.; Biemer, E.: Optimization of 3-dimensional imaging of the breast region with 3-dimensional laser scanners. Annals of Plastic Surgery 56 (3), S. 229 - 236 (2006)

Kluge, M.; Schüssler, P.; Weikel, J.; Dresler, M.; Zuber, V.; Querfurt, F.; Yassouridis, A.; Steiger, A.: Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorders. Psychoneuroendocrinology 31, S. 1098 - 1104 (2006)

Friess, E.; Ambrosius, U.; Lietzenmayer, S.; Wichniak, A.; Winkelmann, J.; Yassouridis, A.; Holsboer, F.: Sleep architecture and sleep continuity in healthy twins. Pharmacopsychiatry 38 (5), S. 241 - 242 (2005)

Kellner, M.; Muhtz, C.; Stark, K.; Yassouridis, A.; Wiedemann, K.: Effects of the metabotropic glutamate type II receptor agonist LY544344 on panic anxiety induced by cholecystokinin tetrapeptide in healthy volunteers. Pharmacopsychiatry 38 (5), S. 253 - 253 (2005)

Rosenhagen, M. C.; Schüssler, P.; Schmidt, U.; Yassouridis, A.; Steiger, A.: Sleep-EEG effects of high-dose corticosteroid treatment in multiple sclerosis. Pharmacopsychiatry 38 (5), S. 273 - 273 (2005)

Schüssler, P.; Kluge, M.; Dresler, M.; Yassouridis, A.; Held, K.; Zihl, J.; Steiger, A.: Effects of progesterone on sleep and cognition in healthy postmenopausal women. Pharmacopsychiatry 38 (5), S. 278 - 278 (2005)

Schüssler, P.; Weikel, J.; Kluge, M.; Dresler, M.; Uhr, M.; Yassouridis, A.; Steiger, A.: The sleep modulating effects of peptides after sleep deprivation. Pharmacopsychiatry 38 (5), S. 277 - 277 (2005)

Kellner, M.; Muhtz, C.; Stark, K.; Yassouridis, A.; Arlt, J.; Wiedemann, K.: Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results. Psychopharmacology 179 (1), S. 310 - 315 (2005)

Steiger, A.; Schüssler, P.; Yassouridis, A.: The effects of growth hormone-releasing hormone and corticotropin-releasing hormone on the recovery sleep after sleep deprivation in normal controls. Naunyn-Schmiedebergs Archives of Pharmacology 371 (Suppl. 1), S. R143 - R143 (2005)

Bender, A.; Auer, D. P.; Merl, T.; Reilmann, R.; Saemann, P.; Yassouridis, A.; Bender, J.; Weindl, A.; Dose, M.; Gasser, T. et al.; Klopstock, T.: Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology 252 (1), S. 36 - 41 (2005)

Himmerich, H.; Koethe, D.; Schuld, A.; Yassouridis, A.; Pollmächer, T.: Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology 179 (2), S. 447 - 451 (2005)

Jahn, H.; Schick, M.; Kiefer, F.; Kellner, M.; Yassouridis, A.; Wiedemann, K.: Metyrapone as additive treatment in major depression - A double-blind and placebo-controlled trial. Archives of General Psychiatry 61 (12), S. 1235 - 1244 (2004)

Kellner, M.; Schick, M.; Yassouridis, A.; Struttmann, T.; Wiedemann, K.; Alm, B.: Metyrapone tests in patients with panic disorder. Biological Psychiatry 56 (11), S. 898 - 900 (2004)

Kellner, M.; Otte, C.; Yassouridis, A.; Schick, M.; Jahn, H.; Wiedemann, K.: Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings. European Neuropsychopharmacology 14 (4), S. 337 - 339 (2004)

Otte, C.; Wiedemann, K.; Yassouridis, A.; Kellner, M.: Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: An open-label study. Journal of Clinical Psychopharmacology 24 (1), S. 106 - 108 (2004)

Arlt, J.; Jahn, H.; Kellner, M.; Ströhle, A.; Yassouridis, A.; Wiedemann, K.: Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide. Neuropeptides 37 (6), S. 362 - 368 (2003)

Jahn, H.; Kiefer, F.; Schick, M.; Yassouridis, A.; Steiger, A.; Kellner, M.; Wiedemann, K.: Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone. Sleep 26 (7), S. 823 - 829 (2003)

Otte, C.; Yassouridis, A.; Jahn, H.; Maass, P.; Stober, N.; Wiedemann, K.; Kellner, M.: Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. Journals of Gerontology Series A-Biological Sciences and Medical Sciences 58 (10), S. 900 - 905 (2003)

Herr, A. S.; Tsolakidou, A.; Yassouridis, A.; Holsboer, F.; Rein, T.: Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Pharmacopsychiatry 36 (5), S. 233 - 233 (2003)